A novel mutation (Thr116Ile) in the presenilin 1 gene in a patient with early-onset Alzheimer's disease

Eur J Neurol. 2004 Aug;11(8):521-4. doi: 10.1111/j.1468-1331.2004.00828.x.

Abstract

We report a novel presenilin 1 (PSN1) mutation (Thr116Ile) in a woman with early onset Alzheimer's disease (AD). This mutation was not found in 100 healthy controls, indicating that this is not a common polymorphism. The patient presented with forgetfulness at age 45, followed over the next 3 years by a worsening of the memory loss and frequent episodes of confusion and spatial disorientation. Neuroimaging studies were consistent with AD. The analysis of the family's pedigree showed that the proband was apparently the only member affected. Because the early death of several close relatives (i.e. the mother and the grandmother) and the demonstration that the father is not a mutation carrier, it is suggested that either a de novo mutation or a censor effect might have occurred. Our finding supports the indication that PSN1 mutations should be searched for in early-onset AD, particularly when a censor effect precludes a precise genetic analysis.

MeSH terms

  • Alzheimer Disease / genetics*
  • DNA Mutational Analysis / methods
  • Female
  • Humans
  • Isoleucine / genetics
  • Membrane Proteins / genetics*
  • Middle Aged
  • Mutation*
  • Presenilin-1
  • Threonine / genetics

Substances

  • Membrane Proteins
  • PSEN1 protein, human
  • Presenilin-1
  • Isoleucine
  • Threonine